Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Don Husereau

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2014
Evolution of drug reimbursement in Canada: the Pan-Canadian Pharmaceutical Alliance for new drugsDon Husereau, William Dempster, Adrienne Blanchard, et al.
Journal of the American College of Radiology : JACR|April 28, 2009
Health technology assessment: a review of international activity and examples of approaches with computed tomographic colonographyDon Husereau, Andra Morrison, Renaldo Battista, et al.
International Journal of Technology Assessment in Health Care|October 22, 2016
CHANGING HEALTH TECHNOLOGY ASSESSMENT PARADIGMS?Don Husereau, Chris Henshall, Laura Sampietro-Colom, et al.
International Journal of Technology Assessment in Health Care|January 10, 2017
CHANGING HEALTH TECHNOLOGY ASSESSMENT PARADIGMS?-ERRATUMDon Husereau, Chris Henshall, Laura Sampietro-Colom, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 30, 2025
Challenges with integrating early-stage cancer trial endpoints into economic models: review of health technology recommendations for adjuvant or neoadjuvant therapies in CanadaJaclyn M Beca, Stephanie Gosselin, Don Husereau, et al.
Journal of Vascular Surgery|June 1, 2019
Variability in aneurysm sac regression after endovascular aneurysm repair based on a comprehensive registry of patients in Eastern OntarioPrasad Jetty, Don Husereau, Vinay Kansal, et al.
Applied Health Economics and Health Policy|October 16, 2014
How do economic evaluations inform health policy decisions for treatment and prevention in Canada and the United States?Don Husereau, Anthony J Culyer, Peter Neumann, et al.
BMC Pulmonary Medicine|September 2, 2004
Long acting beta2 agonists for stable chronic obstructive pulmonary disease with poor reversibility: a systematic review of randomised controlled trialsDon Husereau, Vijay Shukla, Michel Boucher, et al.
International Journal of Technology Assessment in Health Care|June 17, 2009
Health technology assessment in CanadaRenaldo N Battista, Brigitte Côté, Matthew J Hodge, et al.
International Journal of Technology Assessment in Health Care|May 29, 2019
Use of Real-World Data Sources for Canadian Drug Pricing and Reimbursement Decisions: Stakeholder Views and Lessons for Other CountriesDon Husereau, Edward Nason, Tarun Ahuja, et al.
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2014
Evolution of drug reimbursement in Canada: the Pan-Canadian Pharmaceutical Alliance for new drugsDon Husereau, William Dempster, Adrienne Blanchard, et al.
Journal of the American College of Radiology : JACR|April 28, 2009
Health technology assessment: a review of international activity and examples of approaches with computed tomographic colonographyDon Husereau, Andra Morrison, Renaldo Battista, et al.
International Journal of Technology Assessment in Health Care|October 22, 2016
CHANGING HEALTH TECHNOLOGY ASSESSMENT PARADIGMS?Don Husereau, Chris Henshall, Laura Sampietro-Colom, et al.
International Journal of Technology Assessment in Health Care|January 10, 2017
CHANGING HEALTH TECHNOLOGY ASSESSMENT PARADIGMS?-ERRATUMDon Husereau, Chris Henshall, Laura Sampietro-Colom, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 30, 2025
Challenges with integrating early-stage cancer trial endpoints into economic models: review of health technology recommendations for adjuvant or neoadjuvant therapies in CanadaJaclyn M Beca, Stephanie Gosselin, Don Husereau, et al.
Journal of Vascular Surgery|June 1, 2019
Variability in aneurysm sac regression after endovascular aneurysm repair based on a comprehensive registry of patients in Eastern OntarioPrasad Jetty, Don Husereau, Vinay Kansal, et al.
Applied Health Economics and Health Policy|October 16, 2014
How do economic evaluations inform health policy decisions for treatment and prevention in Canada and the United States?Don Husereau, Anthony J Culyer, Peter Neumann, et al.
BMC Pulmonary Medicine|September 2, 2004
Long acting beta2 agonists for stable chronic obstructive pulmonary disease with poor reversibility: a systematic review of randomised controlled trialsDon Husereau, Vijay Shukla, Michel Boucher, et al.
International Journal of Technology Assessment in Health Care|June 17, 2009
Health technology assessment in CanadaRenaldo N Battista, Brigitte Côté, Matthew J Hodge, et al.
International Journal of Technology Assessment in Health Care|May 29, 2019
Use of Real-World Data Sources for Canadian Drug Pricing and Reimbursement Decisions: Stakeholder Views and Lessons for Other CountriesDon Husereau, Edward Nason, Tarun Ahuja, et al.
Pageof 9